Virtual patients could revolutionize cancer drug testing
NCT ID NCT07757022
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This trial is testing whether artificial intelligence can create 'digital twin' models of esophageal cancer patients to predict how they will respond to a combination of immunotherapy and chemotherapy. The study will compare the AI's predictions against real outcomes in patients receiving the treatment. The goal is to see if virtual clinical trials can help personalize treatment and speed up drug development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A combination of toripalimab (an immunotherapy drug), paclitaxel (chemotherapy), and cisplatin (chemotherapy), given before and after surgery.
- What this could lead to
- If successful, this could pave the way for using AI digital twins to predict which drug combinations work best for individual esophageal cancer patients, potentially speeding up treatment discovery and personalizing care.
- What could go wrong
- This is an early-stage approach, and the AI predictions may not match real-world outcomes. The trial is also limited to a specific type of esophageal cancer, so results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Can surgery for stomach or esophageal cancer cloud the mind?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?